CLCN3 Antibody [E24D24] Datasheet

Biological Description

Specificity	CLCN3 Antibody [E24D24] detects endogenous levels of total CLCN3 protein.
Background	CLCN3 (chloride voltage‑gated channel 3) is a broadly expressed ClC‑family 2Cl⁻/H⁺ exchanger that localizes to plasma membranes and intracellular vesicles, where it mediates electrogenic exchange of chloride ions for protons and contributes to acidification of endosomes and synaptic vesicles, regulation of vesicle trafficking and exocytosis, and control of neuronal excitability and smooth muscle activation. The protein is a multi‑pass membrane transporter with a ClC core domain that forms the anion/proton transport pathway and two cytosolic C‑terminal cystathionine‑β‑synthase (CBS) domains that act as regulatory modules; conserved “gating glutamate” residues within the ClC domain define CLCN3 as a proton‑coupled antiporter rather than a simple chloride channel, and the transporter functions as a homodimer, with each subunit containing an independent Cl⁻/H⁺ transport pathway. CLCN3 expression is particularly high in neuroectoderm‑derived tissues and concentrates in hippocampus, olfactory cortex, and olfactory bulb, consistent with its role in synaptic vesicle lumen acidification and transmitter loading at GABAergic terminals, where it complements vesicular H⁺‑ATPases to set the electrochemical environment required for efficient accumulation of neurotransmitters and for proper short‑term synaptic plasticity. The exchanger participates in endosomal acidification and vesicle trafficking more generally, influencing receptor recycling and degradation, and is also required for lysophosphatidic acid–activated chloride currents and fibroblast‑to‑myofibroblast differentiation, implicating CLCN3 in extracellular matrix remodeling and neointima formation during vascular injury, with roles in smooth muscle cell activation and vascular proliferative responses. Regulatory control of CLCN3 involves Ca²⁺/calmodulin‑dependent protein kinase II (CaMKII), which modulates channel activity and surface expression in glioma cells, providing a mechanism by which Ca²⁺‑dependent signaling pathways tune CLCN3‑mediated chloride fluxes and thereby affect cell volume regulation, migration, and invasive behavior in malignant glia. Identification of CLCN3 together with CLCN5 as mediators of sphingosine‑1‑phosphate–induced excitatory chloride currents in sensory neurons links the transporter to neuromodulatory lipid signaling and sensory processing, expanding its functional relevance beyond classical vesicular acidification to acute regulation of membrane potential and nociceptive signaling.

Specificity

CLCN3 Antibody [E24D24] detects endogenous levels of total CLCN3 protein.

Background

CLCN3 (chloride voltage‑gated channel 3) is a broadly expressed ClC‑family 2Cl⁻/H⁺ exchanger that localizes to plasma membranes and intracellular vesicles, where it mediates electrogenic exchange of chloride ions for protons and contributes to acidification of endosomes and synaptic vesicles, regulation of vesicle trafficking and exocytosis, and control of neuronal excitability and smooth muscle activation. The protein is a multi‑pass membrane transporter with a ClC core domain that forms the anion/proton transport pathway and two cytosolic C‑terminal cystathionine‑β‑synthase (CBS) domains that act as regulatory modules; conserved “gating glutamate” residues within the ClC domain define CLCN3 as a proton‑coupled antiporter rather than a simple chloride channel, and the transporter functions as a homodimer, with each subunit containing an independent Cl⁻/H⁺ transport pathway. CLCN3 expression is particularly high in neuroectoderm‑derived tissues and concentrates in hippocampus, olfactory cortex, and olfactory bulb, consistent with its role in synaptic vesicle lumen acidification and transmitter loading at GABAergic terminals, where it complements vesicular H⁺‑ATPases to set the electrochemical environment required for efficient accumulation of neurotransmitters and for proper short‑term synaptic plasticity. The exchanger participates in endosomal acidification and vesicle trafficking more generally, influencing receptor recycling and degradation, and is also required for lysophosphatidic acid–activated chloride currents and fibroblast‑to‑myofibroblast differentiation, implicating CLCN3 in extracellular matrix remodeling and neointima formation during vascular injury, with roles in smooth muscle cell activation and vascular proliferative responses. Regulatory control of CLCN3 involves Ca²⁺/calmodulin‑dependent protein kinase II (CaMKII), which modulates channel activity and surface expression in glioma cells, providing a mechanism by which Ca²⁺‑dependent signaling pathways tune CLCN3‑mediated chloride fluxes and thereby affect cell volume regulation, migration, and invasive behavior in malignant glia. Identification of CLCN3 together with CLCN5 as mediators of sphingosine‑1‑phosphate–induced excitatory chloride currents in sensory neurons links the transporter to neuromodulatory lipid signaling and sensory processing, expanding its functional relevance beyond classical vesicular acidification to acute regulation of membrane potential and nociceptive signaling.

Usage Information

Application

WB, IP, IF

Dilution

WB	IP	IF
1:1000	1:50	1:100

Reactivity

Human, Mouse, Rat

Source

Rabbit Monoclonal Antibody

MW

91 kDa

Storage Buffer

PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage
(from the date of receipt)

-20°C (avoid freeze-thaw cycles), 2 years

References

https://pubmed.ncbi.nlm.nih.gov/7665160/
https://pubmed.ncbi.nlm.nih.gov/29479306/

Application Data

WB

Validated by Selleck

Lane 1: DLD-1, Lane 2: Jurkat, Lane 3: Mouse brain, Lane 4: Rat brain